Work With Us
Partner with PredictCan to Bring Human Diversity Earlier into Drug Development
Whether you are looking to evaluate a compound, develop a new application, or implement our technology within your own organization, PredictCan offers flexible ways to work together.
From tailored preclinical services to scientific collaborations and technology transfer, we help pharmaceutical, biotechnology, academic, and research organizations integrate human-relevant, individual-centric approaches into their development programs.
SERVICES
De-Risk Your Drug Development with Human-Relevant Data
PredictCan provides tailored preclinical services designed to support drug development from early candidate evaluation to advanced preclinical decision-making.
Using our hSEStm platforms, we can evaluate compounds across diverse human biological backgrounds, providing insights that conventional preclinical models may fail to capture.
Our team works closely with yours to design studies aligned with your development objectives—whether you need to screen an early-stage candidate, investigate an unexpected safety signal, assess efficacy, understand interindividual variability, or strengthen a compound package before entering clinical development.
Depending on your program, our services can support:
- Drug safety and DILI risk assessment
- Drug efficacy evaluation
- Population-level and interindividual response analysis
- Identification of susceptible or responsive individuals
- Mechanistic investigations
- Compound benchmarking and candidate prioritization
- AI-powered analysis through PredictCan-MIND™
- Customized study design and scientific support
All projects are conducted under strict confidentiality, with particular attention to the protection of your compounds, data, and intellectual property.
From experimental design to actionable insights
From experimental design to actionable insights
Our scientific team supports you throughout the process—from defining the most relevant experimental strategy to interpreting the generated data—helping you make earlier and more informed go/no-go decisions.
Your compound. The right human models. Better-informed decisions.
COLLABORATION
Let’s Build the Next Generation of Human-Relevant Models Together
PredictCan’s technology was designed to be evolutive, adaptable, and complementary to existing experimental technologies.
Our ambition goes beyond developing a single platform. We want to contribute to a new generation of preclinical research in which human biology, biological diversity, advanced in vitro models, and data science work together to improve the way we evaluate the safety and efficacy of new compounds.
We are therefore open to scientific and technological collaborations with organizations that share our vision of reducing reliance on animal experimentation while developing more predictive tools for human health.
Potential collaborations may include:
- Development of new organ- or disease-specific individual-centric models
- Integration with organoids, MPS, organ-on-chip or other advanced in vitro technologies
- Mechanistic and multi-omics studies
- AI and computational model development
- Biomarker discovery
- Investigation of population-specific drug responses
- Oncology and precision medicine programs
- Environmental and chemical safety applications
- Validation and benchmarking studies
- Regulatory and New Approach Methodology (NAM) initiatives
Your Expertise combined To Our Technology
We believe some of the most valuable innovations emerge when complementary technologies and expertise are brought together.
If your technology, scientific question, or research program could benefit from incorporating human interindividual diversity, we would be interested in exploring what we can build together.
TECHNOLOGY TRANSFER
Bring PredictCan Technology Into Your Own Laboratory
Some organizations need more than an outsourced study. They need the ability to evaluate compounds internally, repeatedly, and within their own development environment.
For these partners, PredictCan offers opportunities to transfer and implement our proprietary technology within qualified laboratories.
Technology transfer can enable pharmaceutical, biotechnology, and research organizations to integrate PredictCan’s individual-centric approach directly into their internal preclinical workflows and use it to support the evaluation and de-risking of their development pipelines.
Depending on the partnership and application, a technology transfer program may include:
- Transfer of experimental protocols and workflows
- Training of scientific and technical teams
- Implementation support
- Access to dedicated know-how and technical expertise
- Integration with existing laboratory workflows
- Ongoing scientific and technical support
- Access to associated analytical solutions, where applicable
Our Technology. Your Laboratory. Your Pipeline
Technology transfer arrangements are developed case by case, taking into account the intended application, infrastructure, level of implementation, intellectual property, and long-term objectives of each partner.
Talk to our team to explore the most appropriate technology transfer, licensing, and implementation model for your organization.